(Total Views: 263)
Posted On: 11/19/2020 7:49:08 PM
Post# of 721
Lexaria Bioscience agrees to sell non-pharmaceutical THC related assets for 3.85 million
Proactive
32 000 prenumeranter
Lexaria Bioscience (CSE: LXX- OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has agreed to sell certain non-core, non-pharmaceutical THC-related business assets to Hill Street Beverage for 3.85 million Canadian.
https://youtu.be/mHthJx3ObGU
Bunka also told Proactive “Hill Street is acquiring royalty-free and perpetual global rights including relicensing rights of Lexaria's DehydraTECH technology” He also said Lexaria retains full ownership of its DehydraTECH technology.
Proactive
32 000 prenumeranter
Lexaria Bioscience (CSE: LXX- OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has agreed to sell certain non-core, non-pharmaceutical THC-related business assets to Hill Street Beverage for 3.85 million Canadian.
https://youtu.be/mHthJx3ObGU
Bunka also told Proactive “Hill Street is acquiring royalty-free and perpetual global rights including relicensing rights of Lexaria's DehydraTECH technology” He also said Lexaria retains full ownership of its DehydraTECH technology.
(1)
(0)
Robert
